‘The data available to our company gives us reason to believe that there is a very considerable under-recording of suspected cases of vaccination side effects after [patients] received the [COVID-19] vaccine,’ wrote board member Andreas Schöfbeck. A large German health insurer has raised concerns over what its data shows to be an excessive underreporting by government authorities of adverse events after experimental COVID-19 gene-based vaccine injections. Andreas Schöfbeck, a board member of BKK ProVita, addressed the company’s findings in a formal letter to the government’s Paul Ehrlich Institute (PEI), which had reported earlier this year that there were 244,576 suspected cases of side effects from the gene-based injections in the calendar year 2021. Extending this rate for the full year, and then applying it to the full population of Germany (around 83 million), one can estimate that likely 2.5 million to 3 million individuals in the nation were treated by medical professionals for such adverse events. “According to our calculations, we consider 400,000 visits to the doctor by our policyholders because of vaccination complications to be realistic to this day. Extrapolated to the total population, this value would be three million,” Schöfbeck told WELT news. This is a “significant alarm signal,” he said in his letter, as it “means around 4-5% of the vaccinated were under medical treatment for side effects,” a rate about 10 times higher than the government’s reported numbers.
Donate And Support The Work I Do Seven Days A Week
Subscribe To The EarthNewspaper.com Daily Newsletter